Ambient Clinical Analytics, the remote patient monitoring firm which became independent from Mayo Clinic in 2013, has elevated $1.5 million in a round led by Noaber Ventures. Noaber Ventures is the extended investment arm of Noaber Foundation and the company’s first European investor. The already existing investors such as Mayo Clinic, Bluestem Capital and Social Capital have also contributed to the round.
Medtronic, a medical technology company, and AI-powered personalized nutrition platform Nutrino, have entered into a partnership. The FoodPrint Report technology of Nutrino is slated to be integrated into the iPro2myLog app of Medtronic, a platform which offers continuous glucose monitor enabling users to gain critical insights into their glucose levels.
Syncona has once again proven its commitment to gene therapy start-up, Freeline Therapeutics with a £85 million investment from the £88 million series B funding round. Freeline’s main focus is on gene therapy for Haemophilia B and Farby disease and this latest cash injection ensures Syncosa’s majority stake in the startup.
In 2015, Apple initiated HELO (Hybridized Emergency Location) a protocol that helps identify a callers’ location using various data such as wifi access points, GPS and cell phone towers. This has now been further developed by RapidSOS to send the data via secure channels to emergency call rooms.
Chief executive Dr. John Thompson, stated that the company also plans on targeting angel investors and a number of high-net-worth individuals in the new funding round. According to another report, AuriGen won a €2.5m funding boost from the EU-backed Horizon 2020 SME funding scheme amidst a lot of competition just last week.
Biopharma Sarepta Therapeutics and Brammer Bio enter into a long-term strategic partnership to design and develop new manufacturing facilities at CDMO’s plant in Massachusetts. The new partnership is for the development of the production of its microdystrophin, Duchenne Muscular Dystrophy (DMD) therapy and future gene therapies.
Sweden-based Telehealth startup Kry has raised $66 million series B funding round led by Index Ventures, with participation from existing investors Creandum, Accel, and Project A. Just a year ago the company raised its venture capital funding of $22.8 Million
San Francisco based Healthcare venture capital firm Alta Partners has launched funds titled as Alta Partner NextGen Fund I. The new fund will focus on the new development of therapeutics and health technology services. This will be the 9th fund in Alta Partners firms History.
Last year the FDA inspected the AbbVie North Chicago manufacturing site during which time they discovered that the company failed to do a proper investigation on five death complaints received relating to Humira and Venclexta treatments. Though the drug maker reported the deaths, it didn’t collate the historical data of the lots in question. It was later discovered that the lots were tied to another 8 to 10 deaths.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.